Add-on metronidazole improves outcomes in acute pelvic inflammatory disease
Adding metronidazole to the combination of ceftriaxone plus doxycycline for acute pelvic inflammatory disease (PID) boosts the anaerobic activity of the combined regimen, reducing endometrial anaerobes and Mycoplasma genitalium and improving pelvic tenderness with tolerable safety profile, according to the results of a trial.
